AlphAIalphai — Financial news for AI agents
benzinga.comAUG 272 min read$VEEV

Veeva Stock Takes Off After Best CRM Quarter Ever: Analysts Approve - Veeva Systems (NYSE:VEEV)

Veeva Systems (NYSE:VEEV) reported Q2 adjusted EPS of $2.35, beating estimates, and raised fiscal 2027 guidance. Analysts increased price targets, citing strong CRM performance and new product demand. Revenue grew 13% YoY, with broad-based growth across segments.

Original reporting
benzinga.com
Published Aug 27, 2026, 5:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 4:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Veeva Stock Takes Off After Best CRM Quarter Ever: Analysts Approve - Veeva Systems (NYSE:VEEV) — source image
Source · benzinga.com
Decision brief

The 30-second read

$VEEVBullishHigh
01

Why it matters

The earnings beat and guidance raise suggest a short‑term bullish catalyst for the stock.

02

Market read

Earnings beat and guidance lift are primary drivers of the stock's surge, offering a clear trading opportunity.

03

What to watch

Potential competition from Salesforce win‑backs could limit long‑term market share.

Relevance 8/10Novelty 8/10Timing: post‑market Thursday

Background

Veeva Systems is a leading provider of cloud‑based software for the life‑sciences industry.

Company-level read

Ticker impact

$VEEVBullishHigh confidence
Context

Veeva reported Q2 earnings beating estimates and raised FY2027 guidance, driving the stock to surge.

Expected impact

Potential further price appreciation as analysts raise targets.

Evidence & confidence

Beat on EPS and revenue, plus guidance lift, are fresh primary facts that typically move the stock.

Market effects

Sector

Life‑sciences SaaS firms may see renewed buying interest.

Regional

U.S. tech and healthcare sectors could benefit from the upbeat earnings.

Global

Positive signal for global CRM and cloud providers serving pharma.

Counterpoint

What could challenge this read

If guidance growth slows in 2028, the current rally may be over‑extended.

Key entities

  • company
    Veeva Systems Inc.

    Provider of CRM and cloud solutions for life‑sciences.

  • analyst
    Needham

    Raised price target to $310.

  • analyst
    Guggenheim

    Raised price target to $310.

  • analyst
    RBC Capital

    Raised price target to $325.

Read at source← All news

Also covered by

3 outlets

Related articles

AUG 28
$VEEVHighAI 9/10

Why Veeva Systems Stock Is Soaring This Week

Veeva Systems (VEEV) stock rose 13.8% after its Q2 fiscal 2027 earnings beat estimates, with adjusted EPS of $2.35 on revenue of $928M, up 18% YoY. The company also raised its full-year guidance above analyst expectations.

fool.com2 min
AUG 28
$VEEVHighAI 9/10

VEEV Looks 3.7% Undervalued on GF Value™

Veeva Systems (VEEV) shares rose 15% to $282.13 after strong quarterly results and raised fiscal 2027 revenue guidance. GF Value™ estimates VEEV is 3.7% undervalued with a GF Score™ of 90/100. Subscription revenue grew 16% YoY to $766.8M, and the company projects $3.68B-$3.69B in revenue for 2027.

gurufocus.com2 min
AUG 27
$VEEVHighAI 8/10

[Veeva Systems Q2 2027 Earnings Call] Veeva Rides Record CRM Quarter and Falcon AI Buzz to $928M Revenue, Up 13% — BigGo Finance

Veeva Systems reported $928M in Q2 2027 revenue, up 13% YoY, with non-GAAP operating income of $416M, exceeding guidance. CEO Peter Gassner highlighted record CRM performance and strong momentum for AI product Falcon. The company raised full-year guidance, citing broad-based commercial strength and strategic product transitions in R&D. Vault CRM gained adoption among top biopharma companies, and Falcon saw high early interest. Aspen, a horizontal CRM startup within Veeva, was noted for its simpl

finance.biggo.com2 min